SCHEMBL6443972

SCHEMBL6443972

COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(OCc2ccc(OC)c(OC)c2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)C)C(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UGT1A1 P22309 2/20 0.52
MLNR O43193 1/20 0.52
NR1I2 O75469 1/20 0.52
SLCO2B1 O94956 1/20 0.52
ABCB11 O95342 1/20 0.52
ABCB1 P08183 1/20 0.52
CCKAR P32238 1/20 0.52
OPRK1 P41145 1/20 0.52
GHSR Q92847 1/20 0.52
SLCO1B3 Q9NPD5 1/20 0.52
ABCG2 Q9UNQ0 1/20 0.52
SLCO1B1 Q9Y6L6 1/20 0.52
CTSD P07339 5/20 0.48
CTSE P14091 1/20 0.48
PGC P20142 1/20 0.48
PSMB11 A5LHX3 1/20 0.45
PSMA7 O14818 1/20 0.45
PSMB1 P20618 1/20 0.45
PSMA1 P25786 1/20 0.45
PSMA2 P25787 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6443968 1.00 UGT1A1 (0.52) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6447945 0.94 CTSD (0.47) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6447948 0.94 CTSD (0.47) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6444845 0.94 CTSD (0.56) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6444841 0.94 CTSD (0.56) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6445121 0.92 CTSD (0.47) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6445117 0.92 CTSD (0.47) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6444918 0.92 UGT1A1 (0.58) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6444921 0.92 UGT1A1 (0.58) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6445577 0.92 MLNR (0.54) UGT1A1MLNRNR1I2SLCO2B1ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050130941-A1 Methods of treating alzheimer's disease PHARMACIA & UPJOHN COMPANY LLC 2005-06-16 US claimed
EP-1392315-A1 METHODS OF TREATING ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-03 EP claimed
WO-2002100410-A1 METHODS OF TREATING ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 WO claimed
US-20050130941-A1 Methods of treating alzheimer's disease PHARMACIA & UPJOHN COMPANY LLC 2005-06-16 US disclosed
EP-1145872-B1 Pneumatic tire YOKOHAMA RUBBER CO LTD (JP) 2005-01-26 EP disclosed
EP-0854054-B1 PNEUMATIC TIRE AND METHOD FOR MANUFACTURING THE SAME YOKOHAMA RUBBER CO LTD (JP) 2004-08-25 EP disclosed
EP-1392315-A1 METHODS OF TREATING ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-03 EP disclosed
WO-2002100410-A1 METHODS OF TREATING ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed
EP-0761477-B1 PNEUMATIC TIRE YOKOHAMA RUBBER CO LTD (JP) 2002-08-07 EP disclosed
EP-0774340-B1 METHOD FOR PRODUCING PNEUMATIC TIRES YOKOHAMA RUBBER CO LTD (JP) 2002-07-24 EP disclosed
US-6402867-B1 Process of production of pneumatic tire THE YOKOHAMA RUBBER CO., LTD. (JP) 2002-06-11 US disclosed
US-5938869-A Pneumatic tire with air permeation preventive layer THE YOKOHAMA RUBBER CO., LTD. (JP) 1999-08-17 US disclosed
US-5919864-A Thermoplastic elastomer composition THE YOKOHAMA RUBBER CO., LTD. (JP) 1999-07-06 US disclosed
EP-0870800-A1 THERMOPLASTIC ELASTOMER COMPOSITIONS, HOSE MADE BY USING THERMOPLASTIC ELASTOMER COMPOSITION, AND PROCESS FOR THE PRODUCTION THEREOF THE YOKOHAMA RUBBER CO., LTD. (JP) 1998-10-14 EP disclosed
EP-0857761-A1 PNEUMATIC TIRE MADE BY USING LOWLY PERMEABLE THERMOPLASTIC ELASTOMER COMPOSITION IN GAS-BARRIER LAYER AND THERMOPLASTIC ELASTOMER COMPOSITION FOR USE THEREIN THE YOKOHAMA RUBBER CO., LTD. (JP) 1998-08-12 EP disclosed
EP-0854054-A1 PNEUMATIC TIRE AND METHOD FOR MANUFACTURING THE SAME THE YOKOHAMA RUBBER CO., LTD. (JP) 1998-07-22 EP disclosed
EP-0842793-A1 PNEUMATIC TYRE THE YOKOHAMA RUBBER CO., LTD. (JP) 1998-05-20 EP disclosed
EP-0774340-A1 METHOD FOR PRODUCING PNEUMATIC TIRES THE YOKOHAMA RUBBER CO., LTD. (JP) 1997-05-21 EP disclosed
EP-0761477-A1 PNEUMATIC TIRE THE YOKOHAMA RUBBER CO., LTD. (JP) 1997-03-12 EP disclosed
EP-0604368-A1 Anti retroviral hydrazine derivatives CIBA-GEIGY AG (CH) 1994-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050130941-A1 Methods of treating alzheimer's disease BACE1, PSEN1, BACE2 UGT1A1 3979/4885MLNR 4496/4885NR1I2 1183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.